Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) will report its fourth quarter and year-end 2020 financial results on February 23, 2021, after market close. Following the announcement, a conference call and webcast will take place at 4:30 p.m. Eastern Time to discuss the results and provide corporate updates. Investors can join the call by dialing specific numbers or access the live webcast via the company’s investor page, with a replay available for 30 days. Adamas aims to deliver innovative medicines addressing neurological diseases.

Positive

• Upcoming financial results could signal growth opportunities.
• Webcast allows for broader investor engagement.

Negative

• None.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, after market close. Subsequently, Adamas’ management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update.

Investor Conference Call and Webcast

The conference call can be accessed by dialing 1-877-407-9716 for participants in the U.S. or Canada and 1-201-493-6779 for international callers. All callers must provide the following Conference ID: 13716505. The webcast can be accessed live via the investor section of the Adamas website at https://ir.adamaspharma.com/events-presentations and will be available for replay for approximately 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210210005279/en/

FAQ

When will Adamas Pharmaceuticals report its fourth quarter 2020 financial results?

Adamas Pharmaceuticals will report its fourth quarter and year-end 2020 financial results on February 23, 2021, after market close.

What time is the investor conference call for Adamas Pharmaceuticals?

The investor conference call will be held at 4:30 p.m. Eastern Time on February 23, 2021.

How can I access the Adamas Pharmaceuticals conference call?

The conference call can be accessed by dialing 1-877-407-9716 for U.S. participants or 1-201-493-6779 for international callers, using Conference ID: 13716505.

Where can I find the live webcast for Adamas Pharmaceuticals' financial results?

The live webcast can be accessed via the investor section of the Adamas Pharmaceuticals website.